Connect with us

Media OutReach

HEAVENS: The Boy and His Robot Soars into New Cinematic Heights with Historic Japan Re-Release and Fantasporto 2025 Debut

Published

on

SINGAPORE – Media OutReach Newswire – 27 February 2025 – Prepare for an interstellar cinematic journey as “HEAVENS: The Boy and His Robot,” a groundbreaking sci-fi adventure from Singapore, 12 years in the making, achieves two unprecedented milestones. On February 28, 2025, this visionary film will be the first Singaporean movie to enjoy a wide special re-release in Japan, screening simultaneously in 50 Aeon Cinemas across the nation. Furthermore, it will make its mark at the prestigious 45th Fantasporto Film Festival in Portugal, becoming the first Singaporean film ever nominated for Best International Feature Film and competing for up to eight additional awards.

HEAVENS: The Boy and His Robot (Mechaverse: Shōnen to Robotto) Official Poster

A Galactic Adventure for All Ages

Official Logline:
In a galaxy fractured by warfare, a young pilot and his loyal robot navigate through a universe in turmoil, to bring peace to the stars. “HEAVENS: The Boy and His Robot” offers a blend of thrilling action, unique humor, and deep emotional resonance, creating a cinematic experience that families across Asia Pacific will treasure.

With its lavish visual effects and compelling narrative, the film has been celebrated by both audiences and critics. Described as “a dream masterpiece” by Aki Suda (菅田愛貴) of Chō Tokimeki Sendenbu, it has been lauded for its “enchanting” visuals and “spectacular” storytelling.

A Historic Re-Release in Japan
The wide re-release in Japan signifies not only a cultural bridge but is also a testament to the film’s universal appeal. This event is a landmark for Singaporean cinema, proving its potential to engage and captivate international audiences beyond arthouse and dramatic films. Critics have hailed it as a pivotal moment, calling the film a “visually impressive blockbuster” and epic heartwarming narrative that resonates with viewers of all ages.

A Grand Debut at Fantasporto 2025
At Fantasporto, one of the world’s premier genre film festivals, “HEAVENS: The Boy and His Robot” stands out among 600 feature film submissions, and was selected as one of only 23 for the feature film competition. “HEAVENS: The Boy and His Robot” will represent the debut of Singapore cinema in Fantasporto’s 45-year history. This nomination not only highlights the film’s artistic merit but also marks a significant achievement for Singaporean filmmakers on the global stage.

A Testament to Creativity and Perseverance
Directed by the visionary Rich Ho, the film is the result of 12 years of dedication and perseverance, reflecting a journey that began from a small modest public housing flat in Singapore. The production traversed global borders and cultures, resulting in a cinematic piece worked on by hundreds of cast and crew from all over the world. “This project was born out of a deep desire to encourage others to never give up. I also wanted to show how, with love and respect (humor and food too), the world can learn to work and walk together towards a common vision,” says Ho, emphasizing the film’s message of hope, collaboration, and the transformative power of dreams.

Critical Acclaim and Industry Praise
With its lavish visual effects and compelling narrative, the film has already made history at multiple international festivals:

  • Fantasporto 2025 (Portugal) – 1st Singaporean film ever nominated for Best International Feature Film in the festival’s 45-year history, eligible for at least eight other awards.
  • Fantasia International Film Festival 2024 (Canada) – 1st Singaporean film ever nominated for Best First International Feature Film in the festival’s 28-year history.
  • Les Utopiales de Nantes 2024 (France) – 1st Singaporean film ever nominated for Best International Feature Film in the festival’s 24-year history.
  • Trieste Science+Fiction Film Festival 2024 (Italy) – Significant nomination for Best International Feature Film (Asteroid Award), though not the first Singaporean film nominated in the festival’s history, it underscores the film’s international recognition.

The film has garnered praise from various quarters:

  • Grant Watson, Fiction Machine: “Boasting lavish visual effects, this science fiction giant robot epic looks just the sort of glossy, visually impressive blockbuster to compete internationally.”
  • Sean Parker, 25YL: “Everything about HEAVENS: The Boy and His Robot is enchanting. It’s a film that proves family adventure can be both heartwarming and spectacular.”
  • Chris Jones, Overly Honest Reviews: “HEAVENS signifies a pivotal moment for the Singaporean cinematic landscape. It reminds us that the boundaries of cinema are as limitless as the universe itself.”
  • Rupert Bottenberg, Fantasia International Film Festival: “Rich Ho’s ambitious and spectacular introduction of his HEAVENS universe has at last launched into the stratosphere. HEAVENS demands to be seen on the biggest screen possible.”
  • Giles Edwards, 366 Weird Movies: “A heartwarming and comedic story about Kai and his Mecha.”
  • Théo Darmana, atuvu.ca: “A science fiction gem that will amaze the whole family.”
  • Zed Kosnar, desdeabajo.net: “HEAVENS is a great example of not giving up when you want to bring your dreams and ideas to life. And we need more of those.”

Join the Journey
Don’t miss your chance to experience this historic moment in theaters, starting with Japan on 28th February 2025. “HEAVENS: The Boy and His Robot” invites families to share in a story where the bond between a boy and his robot can change the fate of worlds.

View HEAVENS: The Boy and His Robot (Mechaverse: Shōnen to Robotto) Official Trailer for Japan here
Hashtag: #heavens_ent_sg #mechaverse_jp #NeverAlone #NeverGiveUp




Official Movie in Japan Website:
Official Japan Twitter/X:
Official Japan Instagram:
Official Facebook:

The issuer is solely responsible for the content of this announcement.

HEAVENS ENTERTAINMENT

Established in 2016, Heavens Entertainment is a Singapore-based company managing the HEAVENS® entertainment franchise. Heavens Entertainment has a global vision to bring to international audiences entertainment that is good, clean and fun.

Heavens Entertainment believes in employing innovative technology and visual effects production methods, introducing massive time and cost savings, in-turn transforming the film and entertainment industry. The HEAVENS® Universe continues to be shaped and formed through such collaborations with like-minded partners and creatives from all over the world.

At the heart of the HEAVENS® franchise is a wish to captivate audiences with stories that inspire, and bring hope and joy. With plans in the pipeline to launch other media platforms, audiences can look forward to experiencing an immersive journey into the HEAVENS® Universe.

For more information about HEAVENS: The Boy and His Robot and Heavens Entertainment, please visit:

Media OutReach

NIA Spotlights Thailand’s Wellness Boom as Global Consumers Spend Boundlessly on Longevity

Published

on

  • Deep dive into the DNA of Thailand’s wellness giants—BDMS Wellness Clinic and Chiva-Som—and their strategic blueprints to transform the kingdom into the ultimate global wellness destination.

BANGKOK, THAILAND – Media OutReach Newswire – 20 July 2026 – In the modern era, “good health” has redefined the meaning of true wealth. Consumers worldwide are now heavily investing in innovations that promote longevity and extend healthspan—the period of life spent in good health. Even amid economic uncertainty, health and well-being remain top priorities for consumers. This behavioral shift helping drive the global wellness economy to a reached USD 6.8 trillion in 2024, representing a 7.9% growth from the previous year. Furthermore, the Global Wellness Institute (GWI) projects the market to surge to USD 9.8 trillion by 2029, maintaining an average annual growth rate of 7.6%. Driven by this exponential growth, nations worldwide, including Thailand, are aggressively developing wellness services and innovations to serve as a “New Growth Engine” and a key indicator of long-term national competitiveness.

NIA Spotlights Thailand’s Wellness Boom

Where Does Thailand Stand in the Global Health & Wellness Industry?

When evaluating Thailand’s potential, Thailand ranks among the world’s leading healthcare destinations. According to the Numbeo Health Care Index 2026, Thailand’s healthcare system is ranked 8th globally, making it the sole ASEAN nation to secure a spot in the Top 10. Focusing specifically on the health and wellness sector, Thailand achieved the highest growth rate globally in 2023, with the market value soaring past USD 40 billion—a remarkable 28.4% increase. The “Wellness Tourism” segment alone skyrocketed by 36.4%, outperforming the global average by threefold.

These figures reflect much more than financial profits; they underscore Thailand’s robust readiness and distinct advantages. The country boasts world-class medical infrastructure, accredited hospitals, highly skilled medical professionals, reasonable treatment costs, and an established reputation as a top wellness destination. Additionally, Thailand possesses unique cultural assets—such as traditional Thai herbs, Thai massage, healthy cuisine, and medical tourism—that can be strategically leveraged into a high-value economy.

Driving a High-Income Economy with Deep Tech in the Wellness Market

Prof. Dr. Yodchanan Wongsawat, Deputy Prime Minister and Minister of Higher Education, Science, Research and Innovation (MHESI), announced a strategic vision to transform Thailand’s wellness industry from traditional services into a high-value, globally competitive innovation sector. The strategy aims to unlock the potential of Thai culture, local wisdom, and rich biodiversity by implementing modern science and technology to establish evidence-based efficacy. Furthermore, cutting-edge innovations such as Health Tech, Artificial Intelligence (AI), and Machine Learning (ML) will be deployed to analyze deep health data. Equipping the sector with Deep Tech will significantly elevate international credibility.

Prof. Dr. Yodchanan emphasized: “MHESI is fully prepared to act as a vital gear in mitigating R&D investment risks for the private sector through an end-to-end support system. We aim to accelerate the commercialization of Thai innovations by systematically connecting the innovation ecosystem. This includes matchmaking entrepreneurs, startups, researchers, and universities, alongside injecting comprehensive financial and resource support. Our assistance spans R&D grants, advanced laboratory access, clinical trials, global production standard upgrades, and intellectual property protection. Collectively, these mechanisms will propel wellness into a New Growth Engine, boosting national competitiveness and establishing Thailand as a true global wellness hub.”

NIA’s Four Strategic Pillars to Propel the Thai Wellness Economy Globally

Dr. Krithpaka Boonfueng, Executive Director of the National Innovation Agency (NIA), stated that driving the wellness industry sustainably cannot be achieved by the private sector alone. It requires cross-sector collaboration to foster an innovation ecosystem conducive to research, technological development, standard testing, and global market expansion. The NIA has continuously supported entrepreneurs in health, wellness, and medical technology through capacity-building initiatives like the Wellness Academy, startup incubation, university network integration, and innovation competitions to translate ideas into market-ready businesses.

The NIA prioritizes data, research, and scientific evidence to build trust and add value to Thai wellness products and services. Simultaneously, the agency connects entrepreneurs to vital resources and innovation networks to stimulate the healthcare economy, creating jobs and new revenue streams through four key strategies:

  1. Connecting Innovative Businesses: Fostering synergies across the ecosystem.
  2. Upgrading Wellness Establishments and Labor Skills: Elevating service standards and workforce capabilities to international levels.
  3. Driving Progress via Thailand Innovation Hubs: Utilizing regional hubs to stimulate localized innovation.
  4. Scaling Up and Building International Recognition: Enhancing global awareness of Thai wellness as credible, safe, verifiable, and uniquely high-value.

The NIA’s ultimate goal is not merely to create new innovative businesses, but to build a sustainable ecosystem that empowers Thai entrepreneurs to grow robustly and integrate seamlessly into the global health and wellness supply chain.

BDMS Champions “Healthspan” and Preventive Medicine to Secure a Competitive Edge

As longevity becomes a primary aspiration for the global population, BDMS Wellness Clinic—a premier wellness leader in Thailand—is accelerating the preventive healthcare industry. By utilizing health science and personalized medicine, the clinic designs deep-level bodily care to firmly establish Thailand as a pioneer in modern health trends.

Dr. Tanupol Virunhagarun, Chief Executive Officer of BDMS Wellness Group, Bangkok Dusit Medical Services Public Company Limited (BDMS), highlighted that transitioning from treating illnesses to preventing them is an undeniable global megatrend. This aligns with World Health Organization (WHO) data indicating that every 1 Baht invested in wellness yields up to a 35-fold return by reducing public healthcare expenditures and enhancing citizen quality of life. This expertise has positioned BDMS Wellness Clinic as a major private-sector anchor, attracting high-spending global consumers to Thailand through its concept of “Scientific Wellness.” This approach features evidence-based healthcare, ranging from advanced genetic testing and personalized nutrition and vitamin formulations to blending modern medical innovations with traditional Thai medicine for verifiable results. Upgrading these standards shifts Thailand’s image from a leisure destination to a highly credible, advanced medical hub, serving as a crucial mechanism in partnering with the government to promote the nation as “Wellness Hub Thailand, The Land of Life” and a top-of-mind Global Wellness Destination.

Chiva-Som Showcases the “Thai Spirit” to Redefine the Health Economy

Complementing advanced medical dimensions, Thailand possesses iconic brands in health tourism marketing, such as Chiva-Som—the country’s first wellness resort and a pioneer in Asia. Spanning over three decades, Chiva-Som evolved from a modest beachfront holiday home in Hua Hin into one of the world’s top wellness resorts, capturing the loyalty of high-net-worth consumers from the West. What sets Chiva-Som apart is not just its world-class international treatments, but the “Thai spirit of hospitality”—characterized by humility, gentleness, and sincerity—seamlessly integrated with a profound understanding of holistic wellness.

Drawing from this tangible success, Mr. Krod Rojanastien, Consultant to President of Chiva-Som International Health Resort Co., Ltd., shared a pivotal insight: In a digital era where people face chronic stress and burnout, wellness has become mainstream. Thailand holds a distinct competitive advantage through its innate service spirit, gentle culture, and centuries-old traditional Thai medical wisdom. Moving forward, the priority must be backing this traditional wisdom with scientific research to secure international trust. Thailand’s future marketing goal must transcend being a temporary vacation spot; it must elevate into a global “Sanctuary” where people intentionally travel to restore their body, mind, and overall quality of life.

When science, technology, innovation, and Thai wisdom are systematically woven together, the wellness economy will transform from a mere service sector into a powerful economic engine. It will lead Thailand toward becoming a definitive Global Wellness Destination, generating economic wealth and holistic well-being simultaneously.
Hashtag: #NIA #NationalInnovationAgency

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM) gathers global experts in Chinese Medicine

Published

on

Concurrent Food Expo features “Multi-Facets of Chinese Medicine” exhibition

HONG KONG SAR – Media OutReach Newswire – 20 July 2026 – The 25th International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), organised by the Modernized Chinese Medicine International Association (MCMIA) together with the HKTDC and ten scientific research institutions, will be held from 13 to 15 August at the Hong Kong Convention and Exhibition Centre (HKCEC), offering industry professionals the latest insights into Chinese medicine. This year’s conference is funded by the Chinese Medicine Development Fund of the Government of the Hong Kong Special Administrative Region. It is dedicated to strengthening the ties between Hong Kong’s Chinese medicine industry and the international market, while promoting Hong Kong’s leading role in the global field of Chinese medicine.

Register for the conference to stay updated with the latest industry information on Chinese medicine: https://tinyurl.com/tmvryr38

Aligning with the strategic Blueprint with a focus on “Bringing In and Going Global”

The Chinese Medicine Development Blueprint of Hong Kong (the Blueprint) released in 2025 positions Hong Kong as a bridgehead for the global internationalisation of Chinese medicine and a key highland within the national framework for Chinese medicine development. To actively support the strategic direction of the Blueprint, this year’s conference adopts the theme Clinical Translation, Regulatory Policies and Global Innovative Pathways of Traditional Medicine, focusing on two core elements: bringing in and going global. It introduces Hong Kong’s Chinese medicine regulations and resource support to participants from Chinese Mainland and overseas, while inviting overseas regulatory authorities to share their local traditional medicine regulations. This year, some 30 experts and scholars from Hong Kong, Chinese Mainland, and overseas have been invited to comprehensively explore the latest research and development trends, regulatory interpretations, and success cases in Chinese medicine.

The three-day conference is divided into five major thematic sessions, covering policy blueprints, international regulations, clinical research, success case sharing, and talent cultivation:

The Chinese Medicine Development Blueprint of Hong Kong, development trends, and government support for the industry

To help enterprises from Chinese Mainland and abroad understand Hong Kong’s Chinese medicine regulation and support, Dr. Vincent Chung Chi-ho, Commissioner for Chinese Medicine Development, Chinese Medicine Unit, Health Bureau, will elaborate on the Blueprint, while Law Kwok-wai, Robert, Chief Pharmacist (Chinese Medicine), Chinese Medicine Regulatory Office, Department of Health, Dr. Yeung Kin Wai, Senior Chemist, Government Chinese Medicines Testing Institute, Department of Health, and Prof. Bian Zhaoxiang, Hospital Chief Executive, The Chinese Medicine Hospital of Hong Kong (CMHHK) , will share in-depth insights into the latest progress in Chinese medicine regulation, quality standards testing, and clinical practice and research at the Chinese Medicine Hospital. Furthermore, Arnold Lau, Associate Director-General, Invest Hong Kong, Dr. William Cheung, Deputy Chief Manager (Life and Health Technology), Office for Attracting Strategic Enterprises (OASES), Angela Yu, Deputy Head of Health Tech and TCM, Hong Kong Productivity Council and Wing Chu, Deputy Director of Research, HKTDC, will participate in a panel discussion to analyse the Hong Kong government’s resource support for the development of Chinese medicine.

International regulations and standards for Chinese medicine and traditional medicine

To provide attendees with a comprehensive analysis of market trends, Prof. Zheng Linyun, Executive Vice President of the Shanghai Academy of International Standardization of Traditional Chinese Medicine, will share reflections and prospects on the transformation of ISO/TC249. Furthermore, Prof. Taruna Ikrar, Chairperson of the Indonesian Food and Drug Authority (BPOM), Indonesia, Nurul Anisah Binti Shahri from National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia and Thawatchai Nakkaratniyom, Senior Professional Level Pharmacist, Head of Pre-marketing Control Group, Herbal Products Division at Thai Food and Drug Administration, Ministry of Public Health, Thailand will jointly analyse the regulations and standards of the Southeast Asian market.

Traditional medicine and Chinese medicine development and clinical research

Scientific and clinical experts will share the latest progress in the scientific research and clinical application of Chinese medicine, as well as experiences regarding the R&D application and clinical efficacy of hospital-made Chinese medicine preparations. Prof. Zhang Zhongde, Deputy President of Guangzhou University of Chinese Medicine & President of Guangdong Provincial Hospital of Chinese Medicine will share Chinese Mainland’s practices in the research and development of Chinese medicine. Prof. Lee Sanghoon, Dean, International Education Institute of Korean Medicine, Kyung Hee University will discuss the development of new natural product drugs in Korea. Prof. Pei Xiaohua, Dean of Changping Hospital Affiliated to Beijing University of Chinese Medicine and Director of the Institute of Traditional Chinese Surgery will discuss clinical needs in developing new Chinese herbal medicines for TCM-advantageous breast diseases. Locally, Prof. Zhang Ge from Hong Kong Baptist University will present innovative achievements in utilising traditional Chinese medicine to drive target discovery for triple-negative breast cancer, while Prof. Xian Yanfang Lisa, Assistant Professor, School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong will share pre-clinical and clinical studies of novel Chinese medicine formula for treating gout.

Sharing of success cases and experience in international Chinese medicine practitioner training

Focusing on successful industry practices, ICMCM provides an interactive platform for the industry, helping to ensure the continuous development and growth of the traditional Chinese medicine sector. Yan Han, Chairman, Beijing Tong Ren Tang Chinese Medicine Company Limited will share the cultural heritage and internationalised development of Chinese medicine, and Dr. Celine Cheng, Chief Compliance & Technology Officer of Jacobson Pharma Corporation Limited will share GMP applications in the industry. Several professors from Chinese Mainland, Australia, Canada, Macao, and Singapore—including Prof. Li Min, Dean and Chair Professor, School of Chinese Medicine, Hong Kong Baptist University; Prof. Xu Hongxi, Chairman, Belt and Road Alliance for Traditional Medicine, Honorary Dean & Distinguished Professor, Shanghai University of Traditional Chinese Medicine; Prof. Zhu Xiaoshu, Co-Director, Australia-China Chinese Medicine Centre, Western Sydney University, Australia; and Prof. Linda Zhong, Director, Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore —will explore training models for Chinese medicine talent at home and abroad, alongside market demands for Chinese medicine products in potential markets.

Talent cultivation: The 22nd International Postgraduate Symposium on Chinese Medicine

The Symposium will be held on the morning of 15 August. This year, it is jointly organized by eight institutions, including four Hong Kong universities—The Chinese University of Hong Kong, The University of Hong Kong, Hong Kong Baptist University, and The Hong Kong University of Science and Technology—alongside Nanyang Technological University in Singapore, the University of Macau, Shanghai University of Traditional Chinese Medicine, and Guangzhou University of Chinese Medicine. The Symposium will kick off with Vincent & Lily Woo Fellowship in Memory of Dr Albert Wong endowed by Vincent & Lily Woo Foundation Award Presentation Ceremony, hosted by the Modernized Chinese Medicine International Foundation. This year’s Symposium will feature nearly 100 research presentations, including oral research presentations by 10 postgraduate students from Hong Kong, Chinese Mainland, Australia, Singapore, South Korea, Vietnam, and Serbia, and nearly 90 poster displays. The judging panel will select 10 winners for the Tianjiang Cup Li Shizhen Youth Outstanding Thesis Award. The Symposium not only provides a platform for postgraduate students in Chinese medicine to share their research progress and achievements but also promotes student collaboration and exchange, laying an important cornerstone for cultivating a new generation of scientific research professionals and driving the development of Chinese medicine.

This year’s conference continues to operate under the hybrid model, with simultaneous interpretation in both English and Putonghua offered to enable wider industry participation.

Concurrent Food Expo features “Multi-Facets of Chinese Medicine” exhibition and ICMCM Public Forum to promote public education

In addition to the professional conference tailored for industry practitioners, ICMCM is committed to promoting the popularisation and implementation of Chinese medicine in the community through a public education display area titled “Multi-Facets of Chinese Medicine” at the concurrent Food Expo. In response to the directives of the Blueprint, this interactive and educational display aims to significantly enhance the public’s correct understanding of and confidence in Chinese medicine.

The design of the exhibition is closely aligned with the development direction set out in the Blueprint, providing a comprehensive overview of the new chapter in Hong Kong’s Chinese medicine sector. It covers four main themes including the latest development trends of Chinese medicine in Hong Kong, the service features of the Chinese Medicine Hospital of Hong Kong, the Hospital Authority’s Chinese medicine outpatient services, Chinese medicine regulation framework and Chinese medicine practitioner registration system, alongside knowledge on Chinese medicine wellness practices.

A half-day ICMCM Public Forum will be held on Saturday, 15, August 2026, to promote the advantages of Chinese medicine services, interesting Chinese medicine wellness tips and preventive healthcare. By running industry conferences alongside public exhibitions and forums in parallel, the event aims, on the one hand, to foster academic and industrial innovation exchanges among global Chinese medicine experts, and on the other, to embed Chinese medicine culture deeply into the daily lives of the public, thereby jointly promoting Hong Kong’s development as an international centre for Chinese medicine.

Conference programme: icmcm.hktdc.com/pdf/2026/programme.pdf
Website: hktdc.com/icmcm

Concurrent Exhibitions:
HKTDC Food Expo PRO foodexpopro.hktdc.com
HKTDC Hong Kong International Tea Fair hkteafair.hktdc.com
HKTDC Food Expo hkfoodexpo.hktdc.com
HKTDC Beauty & Wellness Expo hkbeautyexpo.hktdc.com
HKTDC Home Delights Expo homedelights.hktdc.com

Hashtag: #HKTDC #ICMCM

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

Imperial Harvest Unveils US$1.888 Million Mahjong Set in Singapore, With All Proceeds Pledged to Childhood Brain Cancer Research

Published

on

SINGAPORE – Media OutReach Newswire – 20 July 2026 – Imperial Harvest, an Imperial Feng Shui consultancy in Singapore, has unveiled a one-of-one bespoke mahjong set valued at US$1.888 million (approximately S$2.4 million) — placing it among the world’s most valuable mahjong sets ever created — with all proceeds from its sale pledged to DIPG Foundation Singapore, funding research into one of the deadliest childhood brain cancers.

Imperial Feng Shui Mahjong Set

For generations, mahjong has been far more than a pastime. Rich in symbolism, strategy and tradition, the centuries-old game has long brought families and friends together around a table, and today it is enjoying a global resurgence, winning new audiences across the United States and beyond.

Against this backdrop, the one-of-one creation brings together exceptional materials, artisanal craftsmanship and Imperial Feng Shui principles into a collector’s piece that channels cultural heritage into meaningful change.

Turning Prosperity Into Hope for Children

Diffuse Intrinsic Pontine Glioma (DIPG) is a rare and aggressive brain tumour that primarily affects children between the ages of five and 11, and has long been considered incurable. In 2024, doctors reported the world’s first case of a child effectively cured of DIPG, renewing global momentum in the field — yet research into the disease remains critically underfunded.

All proceeds from the sale of the mahjong set will be donated to DIPG Foundation Singapore, Singapore’s first foundation dedicated to advancing research into DIPG and other paediatric brain cancers. Founded by families who each experienced the loss of a child to the disease, the foundation supports research, advocates for greater access to innovative therapies and clinical trials, and provides resources for affected children and their families.

For Grand Master David Goh, founder of Imperial Harvest, donating the proceeds reflects a belief that prosperity carries its greatest meaning when it can be shared. The mahjong set celebrates abundance through symbolism and craftsmanship while channelling that value into research that brings hope to affected children and their families.

A Fading Craft, Reimagined

The set arrives at a time when the traditional art of mahjong tile carving is fading worldwide, lending its craftsmanship a significance beyond luxury alone. At the heart of the set are 156 playing tiles, including Animal, Fei and Joker tiles, individually crafted in untreated Burmese Grade A Black Jadeite. Revered for its rarity and cultural significance, the stone has long been associated with protection, resilience and prosperity, with every tile retaining its natural individuality.

The tiles are housed in a bespoke trunk wrapped in exceptionally rare Himalayan Niloticus crocodile leather, prized for its naturally occurring gradient reminiscent of snow-capped mountain peaks and sourced from a tannery that supplies some of the world’s most prestigious luxury maisons. Inside, aerospace-grade Alcantara — the same premium material found in the interiors of Ferrari and Lamborghini supercars — creates a soft, durable lining that protects every tile.

Where Feng Shui Meets Design

Guided by third-generation feng shui master Grand Master David Goh, every detail has been considered not only for its visual appeal but also for its symbolic significance, resulting in a collector’s piece that seeks to harmonise Heaven, Earth and humanity.

The conventional Singapore animal tiles have been replaced by the Four Celestial Guardians — the Azure Dragon, Vermilion Phoenix, White Tiger and Black Tortoise — mythical creatures deeply rooted in Chinese cosmology that traditionally represent protection, balance and harmony. Likewise, the flower tiles have been redesigned to depict four auspicious creatures: the bat, deer, crane and magpie, collectively symbolising fortune, prosperity, longevity and happiness.

Even one of mahjong’s most recognisable tiles, the Seven Dots, has been reimagined. Instead of following its conventional arrangement, the seven circles are positioned according to the “Seven Star Lighting” formation, an Imperial Feng Shui configuration believed to represent stability, clarity and strategic balance. The Character suit, meanwhile, features English transliterations such as “Yi Wan”, “Er Wan” and “San Wan”, making the set accessible to an international audience while preserving its cultural identity.

As Grand Master David Goh describes it, the set is “far beyond a Mahjong set. Every detail has been calibrated to harmonise Heaven, Earth and Man, ensuring that its owner engages not just in a game, but in a field of aligned opportunity, protection and infinite prosperity.”

A New Definition of Luxury

Whether viewed as a collector’s piece, a work of design or cultural heritage, the Imperial Feng Shui Mahjong Set occupies a category of its own — a reminder that the greatest luxury may ultimately be the opportunity to create meaningful change. It is a philosophy that Imperial Harvest carries through its bespoke Feng Shui consultation services in Singapore, where prosperity is understood as something to be built, and shared.

Hashtag: #ImperialHarvest #GrandMasterDavidGoh #ImperialHarvestMahjongSet #ImperialFengShui


The issuer is solely responsible for the content of this announcement.

About Imperial Harvest

Imperial Harvest is a Singapore-based luxury Imperial Feng Shui maison dedicated to empowering individuals with clarity, breakthroughs, and prosperity. Founded by Grand Master David Goh, Imperial Harvest upholds the royal Feng Shui traditions once reserved for Chinese emperors, making them accessible to modern professionals, business leaders, and families worldwide.

At the heart of Imperial Harvest is a unique blend of time-honoured metaphysics and contemporary craftsmanship. Every treasure – from fine jadeite and rare agarwood to bespoke jewellery collections – is carefully matched to each client’s Bazi chart and personally blessed by Grand Master David to activate favourable elements for wealth, benefactors, and opportunities.

With a proven track record of guiding thousands of clients to achieve career milestones, business growth, and lasting harmony, Imperial Harvest continues to set the benchmark for authentic, results-driven Imperial Feng Shui. The maison is committed to building lifelong partnerships grounded in trust, expertise, and transformational success.

Continue Reading